Cargando...

Neuroimaging Biomarkers for Clinical Trials of Disease-Modifying Therapies in Alzheimer's Disease

Summary: The pathophysiologic process leading to neurodegeneration in Alzheimer's disease (AD) is thought to begin long before clinical symptoms develop. Existing therapeutics for AD improve symptoms, but increasing efforts are being directed toward the development of therapies to impede the pa...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Dickerson, Bradford C., Sperling, Reisa A.
Formato: Artigo
Idioma:Inglês
Publicado: Am. Soc. for Experimental NeuroTherapeutics 2005
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC1064996/
https://ncbi.nlm.nih.gov/pubmed/15897955
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!